Cargando…
Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer
The eukaryotic translation initiation factor eIF4E is elevated in about 30% of human malignancies including HNSCC where its levels correlate with poor prognosis. Here, we discuss the biochemical and molecular underpinnings of the oncogenic potential of eIF4E. Studies in human leukemia specimens, and...
Autores principales: | Culjkovic, Biljana, Borden, Katherine L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798714/ https://www.ncbi.nlm.nih.gov/pubmed/20049173 http://dx.doi.org/10.1155/2009/981679 |
Ejemplares similares
-
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing
por: Ghram, Mehdi, et al.
Publicado: (2023) -
The Cap-Binding Complex CBC and the Eukaryotic Translation Factor eIF4E: Co-Conspirators in Cap-Dependent RNA Maturation and Translation
por: Mars, Jean-Clement, et al.
Publicado: (2021) -
The eukaryotic translation initiation factor eIF4E elevates steady-state m(7)G capping of coding and noncoding transcripts
por: Culjkovic-Kraljacic, Biljana, et al.
Publicado: (2020) -
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2017) -
The eukaryotic translation initiation factor eIF4E wears a “cap” for many occasions
por: Borden, Katherine L. B.
Publicado: (2016)